Study shows that rare variants captured by Illumina WGS with DRAGEN™ variant calling explain most of the "missing heritability" in complex human diseases and traits, including those related to blood ...
Illumina exhibits better profitability ratios than many of its peers, which indicates that the company could continue to invest in its operations. In Q3 2025, ILMN raised its EPS to $4.65-$4.75, ...
The Illumina Campus in San Diego. (File photo courtesy of the company) Illumina said Wednesday the Chinese Ministry of Commerce will lift its ban on imports of the San Diego company’s gene sequencers ...
China is set to ease restrictions on some Illumina products, giving the sequencing giant a partial reprieve. Since March, Illumina has been barred from exporting its DNA sequencers to China, after ...
This week, the Broad Institute gene-sequencing lab said it read infants’ DNA genomes in less than four hours, cutting an hour off the previous Guinness World Record. The point for investors is that ...
Earlier this year, the U.S. Department of Justice (DOJ) announced Illumina Inc. agreed to pay $9.8 million to resolve allegations under the False Claims Act (FCA) relating to cybersecurity ...
Taiwan-based gene sequencing company Genomics BioSci & Tech has entered a strategic partnership with global sequencing leader Illumina to jointly promote gene sequencing and multi-omics technologies ...
"Illumina has inflicted substantial harm on Element, resulting in lost sales, diminished market share, and reduced profits," counsel for DNA-sequencing company Element Biosciences Inc. alleged in an ...
Sept 22 (Reuters) - Life sciences company Element Biosciences sued Illumina (ILMN.O), opens new tab on Monday in separate cases in federal courts in California and ...
Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. SAN DIEGO — A year ago, Illumina CEO Jacob Thaysen laid out a plan for the genomics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results